Concepedia

Nanxin Zheng

NZ

Statistics

Publications

9

Citations

408

H-Index

9

Active since

2017

Affiliations

Second Military Medical University(Current)

Changhai Hospital

Eastern Hepatobiliary Surgery Hospital

Nanxin Zheng is an author at Second Military Medical University specializing in medicine, oncology, and colorectal cancer.

ORCID

Publications per year

2017–2022

9

Publications

9

N6-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cells

Zhihua Liu, Nanxin Zheng, Juan Li et al. · Drug Resistance Updates · 2022 · 149 citations

, , +17

MiR-199a/b-5p inhibits hepatocellular carcinoma progression by post-transcriptionally suppressing ROCK1

Yangyang Zhan, Nanxin Zheng, Fei Teng et al. · Oncotarget · 2017 · 75 citations · Full text

, , +17

PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN

Xiaodan Chong, Jingde Chen, Nanxin Zheng et al. · Molecular Cancer · 2022 · 47 citations · Full text

, , +17

Wuzhi capsule (Schisandra Sphenanthera extract) attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development

Ziqi Chen, Fang Liu, Nanxin Zheng et al. · Biomedicine & Pharmacotherapy · 2018 · 41 citations · Full text

, , +17

Schisantherin A protects against liver ischemia-reperfusion injury via inhibition of mitogen-activated protein kinase pathway

Nanxin Zheng, Fang Liu, Hao Lu et al. · International Immunopharmacology · 2017 · 35 citations

, , +16

1–5 of 9